Archives
-
Annexin V-APC/7-AAD Apoptosis Kit: Cell Fate
2026-09-08
The Annexin V-APC/7-AAD Apoptosis Kit converts membrane-state changes into a rigorous apoptosis and necrosis readout. This guide connects phosphatidylserine biology with panobinostat studies in MLL-rearranged leukemia and shows how to design more interpretable cell-death experiments.
-
0.4% Trypan Blue Solution: Practical Cell Counting
2026-09-07
0.4% Trypan Blue Solution supports rapid cell viability measurement by separating unstained, membrane-intact cells from blue, membrane-damaged cells during manual or instrument-assisted counting. It is suitable for research cell-counting and selected cytotoxicity workflows, but it is not a diagnostic reagent and cannot by itself identify apoptosis, necrosis, or a specific cause of cell death.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit
2026-09-07
This scenario-driven guide explains how SKU K1061 supports standardized fluorescent RNA probe preparation for in situ hybridization and Northern blot workflows linked to viability, proliferation, and cytotoxicity studies. It separates product-supported workflow guidance from biological interpretation and highlights practical controls, optimization, and vendor-selection considerations.
-
Shh, Fgf10 and Fgfr2 in Penile Development
2026-09-05
A 2025 comparative study identifies differential Shh, Fgf10, and Fgfr2 expression as a major developmental distinction between mouse and guinea pig penile morphogenesis. By combining tissue localization, quantitative gene analysis, and ex vivo perturbation, the work links reduced pathway activity with urethral groove formation and delayed preputial development.
-
Ambroxol Targets in Neuropathic Pain: TRPV1, TRPA1
2026-09-04
This 2025 Journal of Pain study defines a broader mechanistic profile for topical ambroxol by examining human and rat Nav1.8 alongside human TRPV1 and TRPA1 with whole-cell patch clamp recordings. The results show strong species dependence at Nav1.8 and weaker, concentration-dependent modulation of TRPV1 and TRPA1, providing a pharmacological basis for ambroxol’s topical analgesic potential while highlighting important limits for translation.
-
Cell Cycle Assay Kit for Leukemia Research
2026-09-04
Turn PI DNA-content measurements into actionable cell cycle progression analysis, from G0/G1, S, and G2/M distribution to apoptosis detection by sub-G1 peak. This workflow shows how the Cell Cycle Assay Kit (Catalog No. K2263) can help evaluate epigenetic therapy responses in MLL-rearranged leukemia models while exposing common flow cytometry pitfalls.
-
VE-821 ATR Kinase Inhibitor Workflow
2026-09-03
VE-821 is a selective ATR kinase inhibitor for connecting checkpoint biology with radiosensitization, chemotherapy sensitization, and DNA repair pathway research. This workflow also provides a carefully bounded way to test whether ATR signaling influences the DNMT1-dependent replication and RNA-processing phenotypes reported for human bocavirus 1.
-
MK 0893: Discovery of a Glucagon Receptor Antagonist
2026-09-03
The reference study describes the medicinal chemistry optimization and preclinical validation of MK 0893, a potent, reversible, and competitive glucagon receptor antagonist. Its nanomolar activity, receptor selectivity, oral in vivo efficacy, and glucose-lowering effects established a rationale for advancing this scaffold in type 2 diabetes research.
-
Linezolid as a Translational Assay Benchmark
2026-09-02
Linezolid is an oxazolidinone antimicrobial and a useful benchmark for connecting ribosome-proximal assays with whole-cell antibacterial evidence. This article explains how to use it rigorously alongside the MmpL3-focused tuberculosis discovery study without confusing distinct mechanisms or endpoints.
-
Live-Dead Cell Staining Kit I for Ferroptosis
2026-09-02
Use dual Calcein AM/PI fluorescence to distinguish viable mammalian cells from membrane-compromised cells during drug, biomaterial, and cancer experiments. This practical workflow shows how the assay can complement ferroptosis-focused studies without mistaking a live/dead readout for a mechanism-specific endpoint.
-
Staurosporine in Assay-Ready Cell Models
2026-09-01
Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor with powerful applications in apoptosis, angiogenesis, and cancer research. This guide adds a practical perspective by showing how post-thaw cell state and cryopreservation quality can shape kinase-inhibitor assay interpretation.
-
Streptavidin-Cy3 for Biotin Detection
2026-09-01
Streptavidin-Cy3 is a fluorescent streptavidin conjugate for visualizing biotinylated antibodies, proteins, nucleic acids, and other biomolecules. Its four-site biotin-binding tetramer and nominal 554 nm excitation and 568 nm emission maxima support IHC, IF, ISH, ICC, and flow cytometry workflows when storage and spectral controls are maintained.
-
Cannabidiol in Orofacial Inflammatory Pain
2026-08-31
This 2026 study shows that cannabidiol (CBD) can reduce both inflammatory nociception and pain-related affective deficits in mice through coordinated peripheral, central, and serotonergic mechanisms. Its multimodal design links behavioral outcomes with molecular assays and fiber photometry, providing a useful framework for evaluating therapies that address sensory pain together with anxiety, depressive-like behavior, and cognitive impairment.
-
Alternariol, LX-2 Cells, and Liver Fibrosis
2026-08-31
The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can convert LX-2 hepatic stellate cells toward a contractile, extracellular-matrix-producing myofibroblast phenotype, whereas tenuazonic acid produced no significant response under the tested conditions. By combining lncRNA-mRNA omics with phenotypic and pathway analyses, the work connects emerging Alternaria toxins with NF-κB activation, ferroptosis, autophagy-related signaling, and a CotA laccase-based detoxification strategy.
-
U0126: MEK1/2 Inhibitor Workflow Guide
2026-08-30
U0126 provides a cell-permeable, non-ATP-competitive route to test whether MEK1/2 controls ERK-dependent phenotypes. This practical guide connects Raf/MEK/ERK pathway blockade with tau pathology, cancer biology research, and autophagy assays while emphasizing controls, timing, and troubleshooting.